Rejuvenate Bio CEO highlights ambitious approach of using gene therapy to reverse aging
CEO and Co-founder Daniel Oliver share how he and his co-founder started the company and their vision for treating age-related conditions.
Biotech falls short on diversity in workplace, exec teams, according to report
BIO's first annual report on diversity in the workplace found room for improvement, as biotech workforces - especially at the executive level - were found to not represent the U.S. population. The report was based on a survey of nearly 100 companies in late spring 2019.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A decade after biosimilars pathway’s creation, FDA issues final interchangeability rules
The rules are still more restrictive than the European Medicines Agency's, which allow national governments to determine interchangeability. The FDA would require additional testing to demonstrate products can be freely substituted like generic pharmaceuticals.
MedCity News launches biopharma-focused newsletter
The biotech century has arrived, and it's consequently now more important than ever for us to highlight our coverage of biopharma.
Biopharma startup financing had strong showing in 2018, report shows
The report, by PitchBook, shows figures consistent with a similar report earlier this month by Silicon Valley Bank, which forecast more M&A deals this year.
presented by
Bristol-Myers Squibb to acquire Celgene in $74B deal
The acquisition brings together two of the largest drugmakers in the country, both of which are major players in biopharma, particularly oncology.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Blockchain becomes a ‘source of truth’ for biopharma
Although blockchain faces regulatory hurdles and skepticism, its potential as a shared, yet secure ledger system to improve the pharmaceutical supply chain integrity and clinical trials is making it attractive for experimentation and investment by drugmakers.
TraceLink raises $93 million in Series D financing round
The company's life sciences track-and-trace network reaches drugmakers, pharmacies and others, with a customer base of more than 930 companies.
Precision medicine will increase drug prices and that’s a good thing
Precision medicine may also lead to more novel reimbursement structures, such as indication-specific pricing and performance-based pricing.
How will millennials shape the future of the biotech industry?
In many ways, the biotech field is the healthcare equivalent to the Millennial generation.
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
How Biotech Is Revolutionizing Personalized Medicine
In 2005, my late father gave a lecture at Stanford University discussing personalized nutrition for cancer patients. He talked about nutrients that could be absorbed by both normal cells and cancer cells and would be customized to each patient’s unique status. Since then, personalized medicine has rapidly advanced and is becoming an increasingly larger market […]
3 Biotech Trends That Will Change the World
I don’t know about you, but sometimes I think the latest biotechnology developments were ripped from the pages of a science fiction novel. Gene editing cures a little girl’s leukemia; an Italian doctor plans to perform the first human head transplant in 2017; and the U.S. Food and Drug Administration recently approved the first commercial […]
Morning Read: Illumina partners with investors to launch digital hub for genomics
Illumina has partnered with Warburg Pincus and Sutter Hill Ventures to create digital hub Helix for consumers to obtain genetic tests and complementary services from third parties.
As more tech companies enter healthcare, developing clinical trial software poses as many risks as rewards
Taking on clinical trials adds another dimension to the healthIT challenge.
U.S. House overwhelmingly passes 21st Century Cures Act
The bipartisan 21st Century Cures Act is meant to streamline regulatory approval of devices and drugs through the Food and Drug Administration, as well as provide additional research funding for the National Institutes of Health.